|
1.
|
|
17 p, 345.4 KB |
Bone sarcomas : ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
/
Casali, P.G. (University of Milan) ;
Bielack, Stefan S (Klinikum Stuttgart-Olgahospital) ;
Abecassis, N. (Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE) ;
Aro, H.T. (Turku University Hospital (Turun Yliopistollinen Keskussairaala)) ;
Bauer, S. (University Hospital Essen (Alemanya)) ;
Biagini, Roberto (Regina Elena National Cancer Institute) ;
Bonvalot, S. (Institut Curie) ;
Boukovinas, I. (Bioclinic Thessaloniki) ;
Bovee, J.V.M.G. (Leiden University Medical Center) ;
Brennan, B. (Royal Manchester Children's Hospital) ;
Brodowicz, Thomas (Medizinische Universität Wien) ;
Broto, J.M. (Hospital Universitario Virgen Del Rocio-CIBERONC) ;
Brugières, L. (Gustave Roussy Cancer Campus) ;
Buonadonna, A. (Centro di Riferimento Oncologico di Aviano) ;
De Alava, E (Universidad de Sevilla) ;
Dei Tos, A.P. (Ospedale Regionale di Treviso S.Maria di Cà Foncello) ;
Del Muro, X.G. (Integrated Unit ICO Hospitalet) ;
Dileo, P. (University College London Hospitals NHS Trust) ;
Dhooge, C. (Universitair Ziekenhuis Gent) ;
Eriksson, M. (Skåne University Hospital (Suècia)) ;
Fagioli, F. (University of Turin) ;
Fedenko, A. (N. N. Blokhin Russian Cancer Research Center) ;
Ferraresi, V. (Regina Elena National Cancer Institute) ;
Ferrari, A. (Fondazione IRCCS Istituto Nazionale Dei Tumori) ;
Ferrari, S. (Istituto Ortopedico Rizzoli) ;
Frezza, A.M. (Istituto Nazionale Dei Tumori) ;
Gaspar, N. (Gustave Roussy Cancer Campus) ;
Gasperoni, S. (Azienda Ospedaliera Universitaria Careggi Firenze) ;
Gelderblom, H. (Leiden University Medical Centre) ;
Gil, T. (Institut Jules Bordet) ;
Grignani, G. (Candiolo Cancer Institute) ;
Gronchi, A. (University of Milan) ;
Haas, R.L. (Leiden University Medical Centre) ;
Hassan, B. (Oxford University Hospitals NHS Foundation Trust) ;
Hecker-Nolting, S. (Klinikum Stuttgart-Olgahospital) ;
Hohenberger, P. (Mannheim University Medical Center) ;
Issels, R. (University Munich) ;
Joensuu, H. (Helsinki University Central Hospital (HUCH)) ;
Jones, R.L. (Royal Marsden Hospital (Regne Unit)) ;
Judson, I. (Institute of Cancer Research) ;
Jutte, P. (University Medical Center Groningen) ;
Kaal, S. (Radboud University Medical Center) ;
Kager, L. (St. Medical University Vienna) ;
Kasper, B. (Mannheim University Medical Center) ;
Kopeckova, K. (University Hospital Motol) ;
Krákorová, D.A. (Masaryk Memorial Cancer Institute) ;
Ladenstein, R. (Medical University Vienna) ;
Le Cesne, A. (Gustave Roussy Cancer Campus) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Lugowska, I. (Maria Skłodowska Curie Institute-Oncology Centre) ;
Merimsky, O. (Tel Aviv Sourasky Medical Center (Ichilov)) ;
Montemurro, M. (Medical Oncology University Hospital of Lausanne) ;
Morland, B. (Birmingham Women's and Children's NHS Foundation Trust) ;
Pantaleo, M.A. (Policlinico S Orsola-Malpighi Università di Bologna) ;
Piana, R. (University of Turin) ;
Picci, P. (Istituto Ortopedico Rizzoli) ;
Piperno-Neumann, S. (Institut Curie) ;
Reichardt, P. (Helios Klinikum Berlin Buch) ;
Robinson, M.H. (Weston Park Hospital NHS Trust) ;
Rutkowski, P. (Maria Skłodowska Curie Institute-Oncology Centre) ;
Safwat, A.A. (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Schöffski, P. (University Hospitals Leuven (Bèlgica)) ;
Sleijfer, S. (Erasmus MC Cancer Institute) ;
Stacchiotti, S. (Istituto Nazionale Dei Tumori) ;
Strauss, S.J. (University College London Hospitals NHS Trust) ;
Sundby Hall, K. (Norwegian Radium Hospital) ;
Unk, M. (Institute of Oncology of Ljubljana) ;
Van Coevorden, F. (Netherlands Cancer Institute Antoni Van Leeuwenhoek) ;
Van Der Graaf, W.T.A. (Netherlands Cancer Institute Antoni Van Leeuwenhoek) ;
Whelan, J. (Sarcoma Unit. University College London Hospitals NHS Trust) ;
Wardelmann, E. (Universitätsklinikum Münster) ;
Zaikova, O. (Oslo University Hospital (Oslo, Noruega)) ;
Blay, Jean-Yves (Centre Leon Bernard and UCBL1) ;
Universitat Autònoma de Barcelona
2018 -  10.1093/annonc/mdy310
Annals of oncology, Vol. 29 (january 2018) , p. iv79-iv95
|
|
|
2.
|
|
10 p, 1.2 MB |
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
/
Blay, Jean-Yves (Léon Bérard Center (Lyon)) ;
Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Bollard, Julien (Léon Bérard Center (Lyon)) ;
Aguiar Júnior, Samuel (A.C.Camargo Cancer Center (Brasil)) ;
Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ;
Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Badilla-González, Ronald (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ;
Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ;
Caro-Sánchez, C.H.S. (Instituto Nacional de Cancerología (Tlalpan)) ;
Carvajal, B. (Fundación GIST México (Mexico)) ;
Carvajal Montoya, A. (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ;
Clara, Miguel (Instituto Nacional de Cancerología (Tlaplan)) ;
Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ;
Cuellar, M. (Fundación GIST México (Mexico)) ;
Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ;
Dominguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ;
Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Dufresne, Armelle (Léon Bérard Center (Lyon)) ;
Eriksson, Mikael (Skane University Hospital (Lund)) ;
Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Fernandez, Piga (Fundación GIST (Xile)) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ;
Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ;
Gouin, François (Léon Bérard Center (Lyon)) ;
Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Jimenez, Natalia (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Karanian, Marie (Léon Bérard Center (Lyon)) ;
Kasper, Bernd (University of Heidelberg (Mannheim)) ;
Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ;
Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ;
Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ;
Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ;
Morales Pérez, José Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ;
Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ;
Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ;
Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ;
Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ;
Salas, Rodrigo (Fundación GIST México (Mexico)) ;
Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ;
Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Valverde, Claudía María (Hospital Universitari Vall d'Hebron) ;
Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ;
Zamora Estrada, Esteban (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
2022 - 10.1016/j.ctrv.2021.102312
Cancer Treatment Reviews, Vol. 102 (january 2022) , p. 102312
|
|
|
3.
|
|
10 p, 1.4 MB |
SELNET clinical practice guidelines for bone sarcoma
/
Blay, Jean-Yves (Léon Bérard Center (Lyon)) ;
Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Bollard, Julien (Léon Bérard Center) ;
Aguiar Júnior, Samuel (A.C.Camargo Cancer Center) ;
Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ;
Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Badilla-González, Ronald (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ;
Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ;
CHS, Caro Sánchez (Instituto Nacional de Cancerologia (Tlalpan)) ;
Carvajal Montoya, A. (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ;
Clara-Altamirano, Miguel Ángel (Instituto Nacional de Cancerologia (Tlalpan)) ;
Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ;
Cuellar, M. (Instituto Nacional de Cancerologia (Tlalpan)) ;
Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ;
Domínguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ;
Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Dufresne, Armelle (Léon Bérard Center (Lyon)) ;
Eriksson, Mikael (Skane University Hospital (Lund)) ;
Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ;
Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ;
Gouin, François (Léon Bérard Center (Lyon)) ;
Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Jimenez, Natalia (Hospital San Vicente de Paúl (Heredia)) ;
Karanian, Marie (Léon Bérard Center (Lyon)) ;
Kasper, Bernd (University of Heidelberg (Mannheim)) ;
Lopes, Artur (A.C.Camargo Cancer Center (Brasil)) ;
Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ;
Maki, Robert G. (University of Pennsylvania (New York)) ;
Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ;
Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ;
Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ;
Morales Pérez, José Manuel (Hospital Medica Sur (Mexico)) ;
Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Nakagawa, Suely Akiko (A.C.Camargo Cancer Center (Brasil)) ;
Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ;
Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ;
Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ;
Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ;
Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ;
Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ;
Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
MLG, Silva (A.C.Camargo Cancer Center (Brasil)) ;
Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Valverde, Claudia María (Hospital Universitari Vall d'Hebron) ;
Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ;
Zamora Estrada, Esteban (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Bone sarcoma are infrequent diseases, representing < 0. 2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. [...]
2022 - 10.1016/j.critrevonc.2022.103685
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103685
|
|
|
4.
|
|
11 p, 900.3 KB |
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
/
Lewis, James H. (MedStar Georgetown University Hospital) ;
Gelderblom, Hans J (Leiden University Medical Center) ;
van de Sande, Michiel (Leiden University Medical Center (Països Baixos)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Healey, John H. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ;
Tap, William D. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ;
Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Druta, Mihaela (Moffitt Cancer Center (Tampa, Florida)) ;
Lin, ChiaChi Chi Josh (National Taiwan University Hospital (Taipei, Taiwan)) ;
Baba, Hideo Andreas (University Hospital Essen (Alemanya)) ;
Choi, Youngsook (Daiichi Sankyo. Inc (Nova Jersey, Estats Units)) ;
Wang, Qiang (Daiichi Sankyo. Inc (Estats Units)) ;
Shuster, Dale E. (Daiichi Sankyo. Inc (Estats Units))) ;
Bauer, Sebastian (University of Duisburg-Essen (Alemanya))
Background: Pexidartinib is approved in the U. S. for tenosynovial giant cell tumors (TGCTs). Herein, we assessed the hepatic safety profile of pexidartinib across patients with TGCTs receiving pexidartinib. [...]
2021 - 10.1002/onco.13629
The Oncologist, Vol. 26 Núm. 5 (may 2021) , p. e863-e873
|
|
|
5.
|
|
14 p, 2.6 MB |
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
/
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Miah, Aisha B. (The Royal Marsden Hospital) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Messiou, Christina (Department of Radiology. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Morosi, Carlo (Radiology Department. Fondazione IRCCS Istituto Nazionale Tumori) ;
Caraceni, Augusto (Fondazione IRCCS Istituto Nazionale Tumori) ;
Antonescu, Cristina (Memorial Sloan Kettering Cancer Center) ;
Bajpai, Jyoti (Homi Bhabha National Institute. Medical Oncology Department) ;
Baldini, Elizabeth Healey (Dana-Farber Cancer Center/Brigham) ;
Bauer, Sebastian (University of Duisburg-Essen) ;
Biagini, Roberto (Regina Elena National Cancer Institute) ;
Bielack, Stefan S. (Klinikum Stuttgart - Olgahospital) ;
Blay, Jean-Yves (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Bonvalot, Sylvie (Institut Curie. Department of Surgical Oncology) ;
Boukovinas, Ioannis P. (Nordix) ;
Bovee, Judith V.M.G. (Leiden University Medical Center) ;
Boye, Kjetil (The Norwegian Radium Hospital) ;
Brodowicz, Thomas (Medical University Vienna) ;
Callegaro, Dario (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. School of Medicine. University of Seville) ;
Deoras-Sutliff, M. (The EHE Foundation) ;
Dufresne, Armelle (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Eriksson, Mikael (Department of Oncology. Skane University Hospital and Lund University) ;
Errani, Costantino (Orthopaedic Service. Musculoskeletal Oncology Department. IRCCS Istituto Ortopedico Rizzoli) ;
Fedenko, Alexander (Medical Oncology Division. P.A. Herzen Cancer Research Institute) ;
Ferraresi, Virginia (Sarcomas and Rare Tumors Unit. IRCCS Regina Elena National Cancer Institute) ;
Ferrari, Andrea (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Fletcher, Christopher D.M. (Department of Pathology Brigham & Women's Hospital) ;
Garcia del Muro, Xavier (Universitat de Barcelona) ;
Gelderblom, Hans J. (Department of Medical Oncology. Leiden University Medical Center) ;
Gladdy, Rebecca A. (University of Toronto and Lunenfeld-Tanenbaum Research Institute) ;
Gouin, François (Department of Surgery. Centre Leon Berard) ;
Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ;
Gutkovich, J. (NUY Langone Medical Center) ;
Haas, Rick (Department of Radiotherapy. the Leiden University Medical Center) ;
Hindi, Nadia (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ;
Hohenberger, Peter (Mannheim University Medical Center) ;
Huang, Paul (Division of Molecular Pathology. The Institute of Cancer Research) ;
Joensuu, Heikki T. (Department of Oncology. Helsinki University Hospital & Helsinki University) ;
Jones, Robin Lewis (Department of Cancer. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Jungels, Christiane (Institut Jules Bordet. Université Libre de Bruxelles) ;
Kasper, Bernd (University of Heidelberg. Mannheim University Medical Center. Sarcoma Unit) ;
Kawai, Akira (Musculoskeletal Oncology and Rehabilitation Medicine. Rare Cancer Center National Cancer Center Hospital) ;
Le Cesne, Axel (International Department. Gustave Roussy) ;
Le Grange, Franél (UCLH - University College London Hospitals NHS Foundation Trust) ;
Leithner, Andeas (Department of Orthopaedics and Trauma Medical University Graz) ;
Leonard, H. (Chair of Trustees of the EHE Rare Cancer Charity (UK). Charity number 1162472) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Martin Broto, Javier (Hospital Universitario Fundación Jiménez Díaz) ;
Merimsky, Ofer (Unit of Soft Tissue and Bone Oncology. Division of Oncology. Tel-Aviv Medical Center affiliated with Sackler School of Medicine. Tel Aviv University) ;
Merriam, Priscilla (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Mir, Olivier (Sarcoma Group. Gustave Roussy) ;
Molinari, Massimo (University of Pittsburgh Medical Center. Thomas Starzl Transplant Institute) ;
Montemurro, Michael (Oncology. CHUV Lausanne) ;
Oldani, Graziano (Division of Abdominal Surgery. University Hospitals of Geneva) ;
Palmerini, Emanuela (Chemotherapy Unit. IRCCS Istituto Ortopedico Rizzoli) ;
Pantaleo, Maria Abbondanza. (Division of Oncology. IRCCS Azienda Ospedaliero-Universitaria di Bologna) ;
Patel, Sapna Pradyuman (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Piperno-Neumann, Sophie (Department of Medical Oncology. Institut Curie) ;
Raut, Chandrajit Premanand (Dana Farber Cancer Center. Harvard Medical School) ;
Ravi, Vinod (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Razak, Albiruni Ryan Abdul (Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine. University of Toronto) ;
Reichardt, Peter (Helios Klinikum Berlin-Buch. Department of Oncology and Palliative Care) ;
Rubin, Brian P. (Robert J. Tomsich Pathology and Laboratory Medicine Institute. Cleveland Clinic) ;
Rutkowski, Piotr (Maria Sklodowska-Curie National Research Institute of Oncology. Department of Soft Tissue/Bone Sarcoma and Melanoma) ;
Safwat, Akmal Ahmed (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Sapisochin, Gonzalo (Multi-Organ Transplant and HPB Surgical Oncology. Division of General Surgery. Department of Surgery. University of Toronto) ;
Sbaraglia, Marta (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Scheipl, Susanne (Department of Orthopaedics and Trauma. Medical University of Graz) ;
Schöffski, Patrick (Leuven Cancer Institute) ;
Strauss, Dirk Cornelius (Department of Surgery. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Strauss, Sandra J. (University College London Hospital) ;
Sundby Hall, Kirsten (Department of Oncology. Oslo University Hospital. The Norwegian Radium Hospital) ;
Tap, William D. (Department of Medicine. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College) ;
Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Tweddle, A. (Palliative Care. The Royal Marsden Hospital and The Institute of Cancer Research London) ;
van der Graaf, Winette T.A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van de Sande, Michiel (Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit. Leiden University Medical Center) ;
Van Houdt, Winan (Sarcoma and Melanoma Unit. The Netherlands Cancer Institute) ;
van Oortmerssen, Gerard (Co-Chair of Sarcoma Patients EuroNet (SPAEN). Woelfersheim. Germany & Chairman of the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen). Guest researcher at Leiden University (Leiden Institute for Advanced Computer Science). Leiden University) ;
Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Wartenberg, Markus (Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN). Sarcoma Patients EuroNet (SPAEN)) ;
Wood, J. (The Royal Marsden NHS Foundation Trust) ;
Zaffaroni, Nadia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Zimmermann, Camilla (Department of Supportive Care. Princess Margaret Cancer Centre and Division of Palliative Medicine. Department of Medicine. University of Toronto) ;
Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Dei Tos, Angelo (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia))
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. [...]
2021 - 10.1016/j.esmoop.2021.100170
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100170
|
|
|
6.
|
|
9 p, 801.8 KB |
PD-1 Blockade in Anaplastic Thyroid Carcinoma
/
Capdevila Castillón, Jaume (Vall d'Hebron Institut d'Oncologia) ;
Wirth, Lori J. (Harvard Medical School) ;
Ernst, Thomas (Universitätsklinikum Jena) ;
Ponce Aix, Santiago (Hospital Universitario 12 de Octubre (Madrid)) ;
Lin, Chia-Chi (National Taiwan University Hospital (Taipei, Taiwan)) ;
Ramlau, Rodryg (Poznań University of Medical Sciences) ;
Butler, Marcus O. (Princess Margaret Cancer Centre) ;
Delord, Jean-Pierre (IUCT Oncopole) ;
Gelderblom, Hans J (Leiden University Medical Center) ;
Ascierto, Paolo A. (Istituto Nazionale Tumori IRCCS Fondazione G. Pascale) ;
Fasolo, Angelica (San Raffaele Hospital) ;
Führer, Dagmar (University Hospital Essen (Alemanya)) ;
Hütter-Krönke, Marie Luise (University Hospital of Ulm (Alemanya)) ;
Forde, Patrick M. (Sidney Kimmel Comprehensive Cancer Center) ;
Wrona, Anna (Uniwersyteckie Centrum Kliniczne) ;
Santoro, Armando (IRCCS Humanitas University) ;
Sadow, Peter M. (Harvard Medical School) ;
Szpakowski, Sebastian (Novartis Institutes for BioMedical Research) ;
Wu, Hongqian (Novartis Pharmaceuticals) ;
Bostel, Geraldine (Novartis Institutes for BioMedical Research) ;
Faris, Jason (Novartis Institutes for BioMedical Research) ;
Cameron, Scott (Novartis Institutes for BioMedical Research) ;
Varga, Andreea (Gustave Roussy Cancer Campus) ;
Taylor, Matthew (Oregon Health & Science University) ;
Universitat Autònoma de Barcelona
Anaplastic thyroid carcinoma is an aggressive malignancy that is almost always fatal and lacks effective systemic treatment options for patients with BRAF -wild type disease. As part of a phase I/II study in patients with advanced/metastatic solid tumors, patients with anaplastic thyroid carcinoma were treated with spartalizumab, a humanized monoclonal antibody against the programmed death-1 (PD-1) receptor. [...]
2020 - 10.1200/JCO.19.02727
Journal of Clinical Oncology, Vol. 38 Núm. 23 (may 2020) , p. 2620-2627
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
